The incidence of severe bleeding in patients treated with dual antiplatelet therapy, including the new P2Y12 inhibitors or new direct oral anticoagulants, who are undergoing urgent cardiac surgery is very high.Novel strategies, including the removal of antithrombotics via intraoperative hemoadsorption, have shown promising results, which are summarized in this holistic review.Overall, current evidence supports antithrombotic removal via hemoadsorption as a potential new therapy in the management of perioperative bleeding risk in patients on antithrombotic medications undergoing cardiopulmonary bypass-assisted cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Wendt et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: